MigreLief References | MIGRELIEF

All Joints Ultra

Supports joint comfort, strength, mobility and flexibility


  1. Sprangers MA, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53(9):895-907.
  2. Chen D, Shen J, Zhao W, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5:16044. doi:10.1038/boneres.2016.44
  3. What is arthritis? Arthritis Foundation. https://www.arthritis.org/about-arthritis/understanding-arthritis/what-is-arthritis.php. Accessed June 21, 2019.
  4. Arthritis. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/arthritis/symptoms-causes/syc-20350772. Accessed June 21, 2019.
  5. Rahmati M, Nalesso G, Mobasheri A, Mozafari M. Aging and osteoarthritis: Central role of the extracellular matrix. Ageing Res Rev. 2017;40:20-30. doi:10.1016/j.arr.2017.07.004
  6. Arthritis by the Numbers: Book of Trusted Facts and Figures.; 2017. https://www.arthritis.org/Documents/Sections/About-Arthritis/arthritis-facts-stats-figures.pdf.
  7. Wallace IJ, Worthington S, Felson DT, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017;114(35):9332-9336. doi:10.1073/pnas.1703856114
  8. Smolen, JS, Aletaha, D, McInnes I. Rheumatoid arthritis. Lancet. 2016;388(2023-2038).
  9. Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62-68. doi:10.1136/annrheumdis-2013-204223
  10. Hitchon CA, Boire G, Haraoui B, et al. Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. Rheumatology (Oxford). 2016;55(10):1751-1762. doi:10.1093/rheumatology/kew061
  11. Elnady BM, Kamal NM, Shaker RHM, et al. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases. Medicine (Baltimore). 2016;95(38):e4336. doi:10.1097/MD.0000000000004336
  12. Kidd BL, Langford RM, Wodehouse T. Arthritis and pain. Current approaches in the treatment of arthritic pain. Arthritis Res Ther. 2007;9(3):214. doi:10.1186/ar2147
  13. London NJ, Miller LE, Block JE. Clinical and economic consequences of the treatment gap in knee osteoarthritis management. Med Hypotheses. 2011;76(6):887-892. doi:10.1016/j.mehy.2011.02.044
  14. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46-54. doi:10.7326/M14-1231
  15. Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. doi:10.1136/bmj.h1225
  16. Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909. doi:10.1136/bmj.j1909
  17. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016;375(26):2519-2529. doi:10.1056/NEJMoa1611593
  18. Shield MJ. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function. Eur J Rheumatol Inflamm. 1993;13(1):7-16.
  19. Ding C, Cicuttini F, Jones G. Do NSAIDs affect longitudinal changes in knee cartilage volume and knee cartilage defects in older adults? Am J Med. 2009;122(9):836-842. doi:10.1016/j.amjmed.2009.03.022
  20. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-1155. doi:10.1136/ard.2003.011742
  21. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.
  22. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363-388. doi:10.1016/j.joca.2014.01.003
  23. Rutjes AWS, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180-191. doi:10.7326/0003-4819-157-3-201208070-00473
  24. Zink A, Manger B, Kaufmann J, et al. Evaluation of the RABBIT Risk Score for serious infections. Ann Rheum Dis. 2014;73(9):1673-1676. doi:10.1136/annrheumdis-2013-203341
  25. Roubille C, Richer V, Starnino T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(3):480-489. doi:10.1136/annrheumdis-2014-206624
  26. Kirwan JR, Bijlsma JWJ, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane database Syst Rev. 2007;(1):CD006356. doi:10.1002/14651858.CD006356
  27. Wilsdon TD, Hill CL. Managing the drug treatment of rheumatoid arthritis. Aust Prescr. 2017;40(2):51-58. doi:10.18773/austprescr.2017.012
  28. Kelly A, Tymms K, Tunnicliffe DJ, et al. Patients’ Attitudes and Experiences of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis. Arthritis Care Res (Hoboken). 2018;70(4):525-532. doi:10.1002/acr.23329
  29. Krych AJ, Hevesi M, Desai VS, Camp CL, Stuart MJ, Saris DBF. Learning From Failure in Cartilage Repair Surgery: An Analysis of the Mode of Failure of Primary Procedures in Consecutive Cases at a Tertiary Referral Center. Orthop J Sport Med. 2018;6(5):2325967118773041. doi:10.1177/2325967118773041
  30. Pitta M, Esposito CI, Li Z, Lee Y-Y, Wright TM, Padgett DE. Failure After Modern Total Knee Arthroplasty: A Prospective Study of 18,065 Knees. J Arthroplasty. 2018;33(2):407-414. doi:10.1016/j.arth.2017.09.041
  31. Hess DE, Drace P, Franco MJ, Chhabra AB. Failed Thumb Carpometacarpal Arthroplasty: Common Etiologies and Surgical Options for Revision. J Hand Surg Am. 2018;43(9):844-852. doi:10.1016/j.jhsa.2018.03.052
  32. Kim KT, Lee S, Ko DO, Seo BS, Jung WS, Chang BK. Causes of failure after total knee arthroplasty in osteoarthritis patients 55 years of age or younger. Knee Surg Relat Res. 2014;26(1):13-19. doi:10.5792/ksrr.2014.26.1.13
  33. Ganhewa AD, Wu R, Chae MP, et al. Failure Rates of Base of Thumb Arthritis Surgery: A Systematic Review. J Hand Surg Am. 2019;44(9):728-741.e10. doi:10.1016/j.jhsa.2019.05.003
  34. Katz JN, Earp BE, Gomoll AH. Surgical management of osteoarthritis. Arthritis Care Res (Hoboken). 2010;62(9):1220-1228. doi:10.1002/acr.20231
  35. Virolainen P, Aro HT. High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. Arch Orthop Trauma Surg. 2004;124(4):258-261. doi:10.1007/s00402-003-0545-5
  36. Anderson MC, Adams BD. Total wrist arthroplasty. Hand Clin. 2005;21(4):621-630. doi:10.1016/j.hcl.2005.08.014
  37. Malchau H, Herberts P, Eisler T, Garellick G, Soderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am. 2002;84-A Suppl:2-20. doi:10.2106/00004623-200200002-00002
  38. Manley M, Ong K, Lau E, Kurtz SM. Effect of volume on total hip arthroplasty revision rates in the United States Medicare population. J Bone Joint Surg Am. 2008;90(11):2446-2451. doi:10.2106/JBJS.G.01300
  39. Losina E, Barrett J, Mahomed NN, Baron JA, Katz JN. Early failures of total hip replacement: effect of surgeon volume. Arthritis Rheum. 2004;50(4):1338-1343. doi:10.1002/art.20148
  40. Lum ZC, Shieh AK, Dorr LD. Why total knees fail-A modern perspective review. World J Orthop. 2018;9(4):60-64. doi:10.5312/wjo.v9.i4.60
  41. Rammelt S, Panzner I, Mittlmeier T. Metatarsophalangeal Joint Fusion: Why and How? Foot Ankle Clin. 2015;20(3):465-477. doi:10.1016/j.fcl.2015.04.008
  42. Baker JF, England BR, Mikuls TR, et al. Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018;70(12):1740-1747. doi:10.1002/acr.23579
  43. Baker JF, Billig E, Michaud K, et al. Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis. Arthritis Rheumatol (Hoboken, NJ). 2015;67(7):1711-1717. doi:10.1002/art.39136
  44. England BR, Baker JF, Sayles H, et al. Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018;70(1):11-18. doi:10.1002/acr.23258
  45. Dziedzic KS, Allen KD. Challenges and controversies of complex interventions in osteoarthritis management: recognizing inappropriate and discordant care. Rheumatology (Oxford). 2018;57(suppl_4):iv88-iv98. doi:10.1093/rheumatology/key062
  46. White DM, Cibulka MT, Woehrle J. Physical therapy and hip osteoarthritis. JAMA. 2014;312(12):1257. doi:10.1001/jama.2014.9823
  47. Bennell K, Abbott JH. Physical therapy and hip osteoarthritis–reply. JAMA. 2014;312(12):1257-1258. doi:10.1001/jama.2014.9826
  48. Cooney JK, Law R-J, Matschke V, et al. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011;2011:681640. doi:10.4061/2011/681640
  49. Villafane JH. Exercise and osteoarthritis: an update. J Exerc Rehabil. 2018;14(4):538-539. doi:10.12965/jer.1836352.176
  50. Hurley M, Dickson K, Hallett R, et al. Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review. Cochrane database Syst Rev. 2018;4:CD010842. doi:10.1002/14651858.CD010842.pub2
  51. Schiphof D, van den Driest JJ, Runhaar J. Osteoarthritis year in review 2017: rehabilitation and outcomes. Osteoarthr Cartil. 2018;26(3):326-340. doi:10.1016/j.joca.2018.01.006
  52. Bartels EM, Juhl CB, Christensen R, et al. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane database Syst Rev. 2016;3:CD005523. doi:10.1002/14651858.CD005523.pub3
  53. Mann WC, Hurren D, Tomita M. Assistive devices used by home-based elderly persons with arthritis. Am J Occup Ther. 1995;49(8):810-820. doi:10.5014/ajot.49.8.810
  54. Tuntland H, Kjeken I, Nordheim L, Falzon L, Jamtvedt G, Hagen K. The Cochrane review of assistive technology for rheumatoid arthritis. Eur J Phys Rehabil Med. 2010;46(2):261-268.
  55. Veitiene D, Tamulaitiene M. Comparison of self-management methods for osteoarthritis and rheumatoid arthritis. J Rehabil Med. 2005;37(1):58-60. doi:10.1080/16501970410032669
  56. Joo Y-B, Park K-S. Gold Thread Acupuncture for Rheumatoid Arthritis. N Engl J Med. 2017;377(19):e27. doi:10.1056/NEJMicm1706737
  57. Li J, Li Y-X, Luo L-J, et al. The effectiveness and safety of acupuncture for knee osteoarthritis: An overview of systematic reviews. Medicine (Baltimore). 2019;98(28):e16301. doi:10.1097/MD.0000000000016301
  58. Seca S, Patricio M, Kirch S, Franconi G, Cabrita AS, Greten HJ. Effectiveness of Acupuncture on Pain, Functional Disability, and Quality of Life in Rheumatoid Arthritis of the Hand: Results of a Double-Blind Randomized Clinical Trial. J Altern Complement Med. 2019;25(1):86-97. doi:10.1089/acm.2018.0297
  59. Wang C, de Pablo P, Chen X, Schmid C, McAlindon T. Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review. Arthritis Rheum. 2008;59(9):1249-1256. doi:10.1002/art.24009
  60. Chou P-C, Chu H-Y. Clinical Efficacy of Acupuncture on Rheumatoid Arthritis and Associated Mechanisms: A Systemic Review. Evid Based Complement Alternat Med. 2018;2018:8596918. doi:10.1155/2018/8596918
  61. Selfe TK, Taylor AG. Acupuncture and osteoarthritis of the knee: a review of randomized, controlled trials. Fam Community Health. 2008;31(3):247-254. doi:10.1097/01.FCH.0000324482.78577.0f
  62. Field T, Diego M, Gonzalez G, Funk CG. Knee arthritis pain is reduced and range of motion is increased following moderate pressure massage therapy. Complement Ther Clin Pract. 2015;21(4):233-237. doi:10.1016/j.ctcp.2015.08.002
  63. Gok Metin Z, Ozdemir L. The Effects of Aromatherapy Massage and Reflexology on Pain and Fatigue in Patients with Rheumatoid Arthritis: A Randomized Controlled Trial. Pain Manag Nurs. 2016;17(2):140-149. doi:10.1016/j.pmn.2016.01.004
  64. Shetty GB, Mooventhan A, Anagha N. Effect of electro-acupuncture, massage, mud, and sauna therapies in patient with rheumatoid arthritis. J Ayurveda Integr Med. 2015;6(4):295-299. doi:10.4103/0975-9476.172415
  65. Nelson NL, Churilla JR. Massage Therapy for Pain and Function in Patients With Arthritis: A Systematic Review of Randomized Controlled Trials. Am J Phys Med Rehabil. 2017;96(9):665-672. doi:10.1097/PHM.0000000000000712
  66. Pure E, Terhorst L, Baker N. Movement and manual therapy for adults with arthritis: 2012 National Health Interview Survey. Complement Ther Med. 2018;37:96-102. doi:10.1016/j.ctim.2018.02.007
  67. Perlman A, Fogerite SG, Glass O, et al. Efficacy and Safety of Massage for Osteoarthritis of the Knee: a Randomized Clinical Trial. J Gen Intern Med. 2019;34(3):379-386. doi:10.1007/s11606-018-4763-5
  68. Bahr T, Allred K, Martinez D, Rodriguez D, Winterton P. Effects of a massage-like essential oil application procedure using Copaiba and Deep Blue oils in individuals with hand arthritis. Complement Ther Clin Pract. 2018;33:170-176. doi:10.1016/j.ctcp.2018.10.004
  69. Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10):642-650. doi:10.1136/bjsports-2017-098043
  70. Rodriguez-Merchan EC. Topical therapies for knee osteoarthritis. Postgrad Med. 2018;130(7):607-612. doi:10.1080/00325481.2018.1505182
  71. Honvo G, Leclercq V, Geerinck A, et al. Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs Aging. 2019;36(Suppl 1):45-64. doi:10.1007/s40266-019-00661-0
  72. Stanos SP. Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs. J Multidiscip Healthc. 2013;6:133-137. doi:10.2147/JMDH.S35229
  73. Topp R, Brosky JAJ, Pieschel D. The effect of either topical menthol or a placebo on functioning and knee pain among patients with knee OA. J Geriatr Phys Ther. 2013;36(2):92-99. doi:10.1519/JPT.0b013e318268dde1
  74. Argoff CE, Gloth FM. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients. Ther Clin Risk Manag. 2011;7:393-399. doi:10.2147/TCRM.S24458
  75. Rannou F, Pelletier J-P, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S18-21. doi:10.1016/j.semarthrit.2015.11.007
  76. Altman R, Barkin RL. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med. 2009;121(2):139-147. doi:10.3810/pgm.2009.03.1986
  77. Persson MSM, Stocks J, Walsh DA, Doherty M, Zhang W. The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthr Cartil. 2018;26(12):1575-1582. doi:10.1016/j.joca.2018.08.008
  78. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther. 1991;13(3):383-395.
  79. Komeh-Nkrumah SA, Nanjundaiah SM, Rajaiah R, Yu H, Moudgil KD. Topical dermal application of essential oils attenuates the severity of adjuvant arthritis in Lewis rats. Phytother Res. 2012;26(1):54-59. doi:10.1002/ptr.3509
  80. Sen R, Hurley JA. Osteoarthritis. In: Treasure Island (FL); 2019.
  81. Hunter DJ, Felson DT. Osteoarthritis. BMJ. 2006;332(7542):639-642. doi:10.1136/bmj.332.7542.639
  82. Mora JC, Przkora R, Cruz-Almeida Y. Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 2018;11:2189-2196. doi:10.2147/JPR.S154002
  83. Khlopas H, Khlopas A, Samuel LT, et al. Current Concepts in Osteoarthritis of the Ankle: Review. Surg Technol Int. 2019;35:280-294.
  84. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175. doi:10.1136/bjsports-2016-097333
  85. Liu X, Eyles J, McLachlan AJ, Mobasheri A. Which supplements can I recommend to my osteoarthritis patients? Rheumatology (Oxford). 2018;57(suppl_4):iv75-iv87. doi:10.1093/rheumatology/key005
  86. Henrotin Y, Lambert C, Couchourel D, Ripoll C, Chiotelli E. Nutraceuticals: do they represent a new era in the management of osteoarthritis? – a narrative review from the lessons taken with five products. Osteoarthr Cartil. 2011;19(1):1-21. doi:10.1016/j.joca.2010.10.017
  87. Davis JL. Alternatives and supplements for arthritis joint pain. WebMD. https://www.webmd.com/arthritis/features/alternatives-and-supplements-for-arthritis-joint-pain#1. Accessed April 15, 2019.
  88. Feverfew. NIH. https://nccih.nih.gov/health/feverfew. Accessed January 31, 2020.
  89. Pareek A et al. Feverfew (Tanacetum parthenium L.) A systematic review. Pharmacogn Rev. 2011;5(9):103-110.
  90. Salan S. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components. Biochem Pharmacol. 1992;43(11):2313-2320.
  91. Tomita T et al. Application of NFkappaB inhibitor for arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 2009;32(2):71-76.
  92. Chen, CF & Cheng C. Regulation of cellular metabolism and cytokines by the medicinal herb feverfew in the human monocytic THP-1 cells. Evid Based Complement Altern Med. 2009;6(1):91-98.
  93. Ramadan G, El-Menshawy O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis. Int J Rheum Dis. 2013;16(2):219-229. doi:10.1111/1756-185X.12054
  94. Ribel-Madsen S, Bartels EM, Stockmarr A, et al. A synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in vitro study. Arthritis. 2012;2012:505842. doi:10.1155/2012/505842
  95. Phan P V, Sohrabi A, Polotsky A, Hungerford DS, Lindmark L, Frondoza CG. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Altern Complement Med. 2005;11(1):149-154. doi:10.1089/acm.2005.11.149
  96. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses. 1992;39(4):342-348. doi:10.1016/0306-9877(92)90059-l
  97. Bartels EM, Folmer VN, Bliddal H, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthr Cartil. 2015;23(1):13-21. doi:10.1016/j.joca.2014.09.024
  98. Drozdov VN, Kim VA, Tkachenko E V, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Altern Complement Med. 2012;18(6):583-588. doi:10.1089/acm.2011.0202
  99. Therkleson T. Ginger Therapy for Osteoarthritis: A Typical Case. J Holist Nurs. 2014;32(3):232-239. doi:10.1177/0898010113520467
  100. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44(11):2531-2538. doi:10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j
  101. Skoczynska M, Swierkot J. The role of diet in rheumatoid arthritis. Reumatologia. 2018;56(4):259-267. doi:10.5114/reum.2018.77979
  102. Aryaeian N, Shahram F, Mahmoudi M, et al. The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active Rheumatoid Arthritis. Gene. 2019;698:179-185. doi:10.1016/j.gene.2019.01.048
  103. Amorndoljai P, Taneepanichskul S, Niempoog S, Nimmannit U. Improving of Knee Osteoarthritic Symptom by the Local Application of Ginger Extract Nanoparticles: A Preliminary Report with Short Term Follow-Up. J Med Assoc Thai. 2015;98(9):871-877.
  104. Funk JL, Frye JB, Oyarzo JN, Chen J, Zhang H, Timmermann BN. Anti-Inflammatory Effects of the Essential Oils of Ginger (Zingiber officinale Roscoe) in Experimental Rheumatoid Arthritis. PharmaNutrition. 2016;4(3):123-131. doi:10.1016/j.phanu.2016.02.004
  105. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3-7. doi:10.1078/094471103321648593
  106. Ammon HPT. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100-1116. doi:10.1055/s-2006-947227
  107. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349-369. doi:10.2165/11586800-000000000-00000
  108. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(3):416-429. doi:10.1016/j.semarthrit.2018.03.001
  109. Del Grossi Moura M, Lopes LC, Biavatti MW, et al. Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis. Phytother Res. 2017;31(11):1676-1685. doi:10.1002/ptr.5910
  110. Umar S, Umar K, Sarwar AHMG, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014;21(6):847-856. doi:10.1016/j.phymed.2014.02.001
  111. Ricci M, Micheloni GM, Berti M, et al. Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet Surg. 2017;101(1):45-49. doi:10.1007/s12306-016-0428-x
  112. Oe M, Tashiro T, Yoshida H, et al. Oral hyaluronan relieves knee pain: a review. Nutr J. 2016;15:11. doi:10.1186/s12937-016-0128-2
  113. Vingender S, Restar L, Csomo KB, Schmidt P, Hermann P, Vaszilko M. [Intra-articular steroid and hyaluronic acid treatment of internal derangement of the temporomandibular joint]. Orv Hetil. 2018;159(36):1475-1482. doi:10.1556/650.2018.31138
  114. Nelson FR, Zvirbulis RA, Zonca B, et al. The effects of an oral preparation containing hyaluronic acid (Oralvisc(R)) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses. Rheumatol Int. 2015;35(1):43-52. doi:10.1007/s00296-014-3047-6
  115. Hatayama T et al. The effect of a supplement on knee pain and discomfort evaluated by visual analogue scale (VAS): A randomized, double-blind, placebo-controlled study. Kenkoshien. 2008;10.
  116. Kalman D et al. Effect of a natural extract of chicken combs with a high content of hyaluronic acidOral hyaluronan relieves knee pain: a reviewain relief and qualify of life in subjects with knee osteoarthritis: A pilot randomized double-blind placebo-controlled trial. Nutr J. 2008;7.
  117. Avenoso A, D’Ascola A, Scuruchi M, et al. Hyaluronan in experimental injured/inflamed cartilage: In vivo studies. Life Sci. 2018;193:132-140. doi:10.1016/j.lfs.2017.11.006
  118. Tamer TM. Hyaluronan and synovial joint: function, distribution and healing. Interdiscip Toxicol. 2013;6(3):111-125. doi:10.2478/intox-2013-0019
  119. Oldroyd KG, Dawes PT. Clinically significant vitamin C deficiency in rheumatoid arthritis. Br J Rheumatol. 1985;24(4):362-363. doi:10.1093/rheumatology/24.4.362
  120. Chiu P-R, Hu Y-C, Huang T-C, et al. Vitamin C Protects Chondrocytes against Monosodium Iodoacetate-Induced Osteoarthritis by Multiple Pathways. Int J Mol Sci. 2016;18(1). doi:10.3390/ijms18010038
  121. Peregoy J, Wilder FV. The effects of vitamin C supplementation on incident and progressive knee osteoarthritis: a longitudinal study. Public Health Nutr. 2011;14(4):709-715. doi:10.1017/S1368980010001783
  122. Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994;102 Suppl:83-85. doi:10.1289/ehp.94102s783
  123. Korkmaz M, Turkmen R, Demirel HH, Saritas ZK. Effect of Boron on the Repair of Osteochondral Defect and Oxidative Stress in Rats: an Experimental Study. Biol Trace Elem Res. 2019;187(2):425-433. doi:10.1007/s12011-018-1381-3
  124. Mogosanu GD, Bita A, Bejenaru LE, et al. Calcium Fructoborate for Bone and Cardiovascular Health. Biol Trace Elem Res. 2016;172(2):277-281. doi:10.1007/s12011-015-0590-2
  125. Scorei R, Mitrut P, Petrisor I, Scorei I. A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res. 2011;144(1-3):253-263. doi:10.1007/s12011-011-9083-0
  126. Li Y, Yue J, Yang C. Unraveling the role of Mg(++) in osteoarthritis. Life Sci. 2016;147:24-29. doi:10.1016/j.lfs.2016.01.029
  127. Zeng C, Wei J, Li H, et al. Relationship between Serum Magnesium Concentration and Radiographic Knee Osteoarthritis. J Rheumatol. 2015;42(7):1231-1236. doi:10.3899/jrheum.141414
  128. Zeng C, Li H, Wei J, et al. Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis. PLoS One. 2015;10(5):e0127666. doi:10.1371/journal.pone.0127666
  129. Zeng C, Wei J, Terkeltaub R, et al. Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis. Arthritis Res Ther. 2017;19(1):236. doi:10.1186/s13075-017-1450-6
  130. Veronese N, La Tegola L, Caruso MG, Maggi S, Guglielmi G. The Association between Dietary Magnesium Intake and Magnetic Resonance Parameters for Knee Osteoarthritis. Nutrients. 2019;11(6). doi:10.3390/nu11061387
  131. Shahi A, Aslani S, Ataollahi M, Mahmoudi M. The role of magnesium in different inflammatory diseases. Inflammopharmacology. 2019;27(4):649-661. doi:10.1007/s10787-019-00603-7
  132. Farsinejad-Marj M, Saneei P, Esmaillzadeh A. Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis. Osteoporos Int. 2016;27(4):1389-1399. doi:10.1007/s00198-015-3400-y
  133. Brodziak-Dopierala B, Kwapulinski J, Sobczyk K, Wiechula D. Distribution of magnesium, calcium, sodium and potassium in tissues of the hip joint. Magnes Res. 2013;26(3):125-131. doi:10.1684/mrh.2013.0348
  134. Wu Z, Yang J, Liu J, Lian K. The relationship between magnesium and osteoarthritis of knee: A MOOSE guided systematic review and meta-analysis. Medicine (Baltimore). 2019;98(45):e17774. doi:10.1097/MD.0000000000017774
  135. Vangsness CTJ, Spiker W, Erickson J. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis. Arthroscopy. 2009;25(1):86-94. doi:10.1016/j.arthro.2008.07.020
  136. Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. 2009;13(52):1-148. doi:10.3310/hta13520
  137. Reginster J-Y, Neuprez A, Lecart M-P, Sarlet N, Bruyere O. Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int. 2012;32(10):2959-2967. doi:10.1007/s00296-012-2416-2
  138. Giordano N et al. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial. Curr Ther Res Clin Exp. 2009;70(3):185-196.
  139. Bruyere O, Pavelka K, Rovati LC, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause. 2004;11(2):138-143.
  140. Simanek V, Kren V, Ulrichova J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):51-56.
  141. Morita M, Yamada K, Date H, Hayakawa K, Sakurai H, Yamada H. Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan. Biol Pharm Bull. 2018;41(2):163-171. doi:10.1248/bpb.b17-00556
  142. Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas. 2014;78(3):184-187. doi:10.1016/j.maturitas.2014.04.015
  143. Bruyere O, Reginster J-Y. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging. 2007;24(7):573-580. doi:10.2165/00002512-200724070-00005
  144. Knapik J et al. Effects of oral chondroitin sulfate on osteoarthritis-related pain and joint structural changes: Systematic review and meta-analysis. J Spec Oper Med. 2019;19(1):113-124.
  145. Knapik J et al. Effects of oral glucosamine sulfate on osteoarthritis-related pain and joint-space changes: Systematic review and meta-analysis. J Spec Oper Med. 2018;18(4):139-147.
  146. Kwoh C et al. Effect of oral glucosamine on joint structure in individuals with chronic knee pain. Arthritis Rheumatol. 2014;66(4):930-939.
  147. Okazaki J, Kakudo K, Kamada A, et al. Chondroitin sulfate isomers in synovial fluid of healthy and diseased human temporomandibular joints. Eur J Oral Sci. 1997;105(5 Pt 1):440-443.
  148. DiNubile N. Glucosamine and chondroitin sulfate: What has been learned since the glucosamine/chondroitin arthritis intervention trial. Orthopedics. 2018;41(4):200-207.
  149. Zhu X et al. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2018;13(1):170.
  150. Vasiliadis HS, Tsikopoulos K. Glucosamine and chondroitin for the treatment of osteoarthritis. World J Orthop. 2017;8(1):1-11. doi:10.5312/wjo.v8.i1.1
  151. Lee YH, Woo J-H, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30(3):357-363. doi:10.1007/s00296-009-0969-5
  152. Bruyere O, Altman RD, Reginster J-Y. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12-7. doi:10.1016/j.semarthrit.2015.11.011
  153. Jerosch J. Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: Outlook on other nutrient partners especially omega-3 fatty acids. Int J Rheumatol. 2011;969012.
  154. da Camara, CC & Dowless G. Glucosamine sulfate for osteoarthritis. Ann. 1998;32(5):580-587.
  155. Mankia K, Emery P. A new window of opportunity in rheumatoid arthritis: targeting at-risk individuals. Curr Opin Rheumatol. 2016;28(3):260-266. doi:10.1097/BOR.0000000000000268
  156. Anandacooomarasamy, A & March L. Current evidence for osteoarthritis treatments. Ther Adv Musculoskelet Dis. 2010;2(1):17-28.
  157. Puigdellivol J, Comellas Berenger C, Perez Fernandez MA, et al. Effectiveness of a Dietary Supplement Containing Hydrolyzed Collagen, Chondroitin Sulfate, and Glucosamine in Pain Reduction and Functional Capacity in Osteoarthritis Patients. J Diet Suppl. April 2018:1-11. doi:10.1080/19390211.2018.1461726